VPS53 Protein

VPS53 Protein — Vacuolar Protein Sorting 53

Introduction

VPS53 (Vacuolar Protein Sorting 53) is a critical core component of two related vesicle tethering complexes—HOPS (Homotypic fusion and Vacuolar Protein Sorting) and CORVET (Class C Core Vacuolar/Endosomal Tethering).[@corvet2016] These complexes are essential for mediating membrane fusion events in the endosomal-lysosomal pathway, which is fundamental to cellular homeostasis, protein degradation, and autophagy. VPS53 plays a central role in tethering late endosomes and autophagosomes to lysosomes, enabling the proper degradation of protein aggregates, damaged organelles, and cellular debris—processes that are particularly important in neurons given their long lifespan and non-dividing nature.

The discovery that VPS53 mutations cause autosomal recessive hereditary spastic paraplegia (HSP) with neurodevelopmental regression ([Bomont et al., 2020](https://pubmed.ncbi.nlm.nih.gov/33207047/)) has highlighted the critical importance of this protein in human neurological function.[@vps2020] Furthermore, dysfunction of the HOPS complex, which includes VPS53 as a core subunit, has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease ([Miller et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30712917/)).[@hops2019] This makes VPS53 an important protein for understanding neurodegenerative disease mechanisms and potentially for therapeutic targeting.

Historical Background

VPS53 Protein — Vacuolar Protein Sorting 53

Introduction

VPS53 (Vacuolar Protein Sorting 53) is a critical core component of two related vesicle tethering complexes—HOPS (Homotypic fusion and Vacuolar Protein Sorting) and CORVET (Class C Core Vacuolar/Endosomal Tethering).[@corvet2016] These complexes are essential for mediating membrane fusion events in the endosomal-lysosomal pathway, which is fundamental to cellular homeostasis, protein degradation, and autophagy. VPS53 plays a central role in tethering late endosomes and autophagosomes to lysosomes, enabling the proper degradation of protein aggregates, damaged organelles, and cellular debris—processes that are particularly important in neurons given their long lifespan and non-dividing nature.

The discovery that VPS53 mutations cause autosomal recessive hereditary spastic paraplegia (HSP) with neurodevelopmental regression ([Bomont et al., 2020](https://pubmed.ncbi.nlm.nih.gov/33207047/)) has highlighted the critical importance of this protein in human neurological function.[@vps2020] Furthermore, dysfunction of the HOPS complex, which includes VPS53 as a core subunit, has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease ([Miller et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30712917/)).[@hops2019] This makes VPS53 an important protein for understanding neurodegenerative disease mechanisms and potentially for therapeutic targeting.

Historical Background

The study of VPS53 and the HOPS/CORVET complexes has evolved from basic yeast genetics to a detailed understanding of their critical roles in mammalian neurobiology:

Overview

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">VPS53 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Vacuolar Protein Sorting 53</td></tr>
<tr><td><strong>Gene</strong></td><td>[VPS53](/genes/vps53)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9H5R0](https://www.uniprot.org/uniprot/Q9H5R0)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>6Q19, 6Q1A</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>79 kDa (672 aa)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Endosomes, Lysosomes, Golgi apparatus</td></tr>
<tr><td><strong>Protein Family</strong></td><td>HOPS complex, CORVET complex</td></tr>
<tr><td><strong>Tissue Distribution</strong></td><td>Brain (neurons, glia), ubiquitous</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Structure

VPS53 is a 672-amino acid protein with a molecular weight of approximately 79 kDa. The protein contains several structural domains that enable its function in the HOPS and CORVET complexes:

Domain Architecture

• N-terminal domain (aa 1-200): Interactions with other HOPS/CORVET subunits, particularly VPS16 and VPS33. This region contains binding sites for the core complex assembly.
• Central region (aa 200-450): Scaffold for complex formation, providing the structural framework for the hexameric HOPS complex. This region contains alpha-helical domains that mediate subunit-subunit interactions.
• C-terminal region (aa 450-672): Conserved WD40-like beta-propeller repeats that may function in protein-protein interactions and membrane recognition. This domain is important for cargo recognition and recruitment.

Structural Insights

Crystal structures of the VPS53-containing HOPS complex have revealed ([Ostrowicz et al., 2015](https://pubmed.ncbi.nlm.nih.gov/25747449/)):

• The HOPS complex forms a elongated, tweezer-like structure that can bridge two membranes
• VPS53 and VPS52 form a subcomplex that connects the core to the peripheral subunits
• The complex undergoes conformational changes during the fusion process
• Multiple SM proteins (Sec1/Munc18) work with HOPS to regulate SNARE complex assembly

Post-Translational Modifications

• Phosphorylation: VPS53 can be phosphorylated at multiple serine/threonine residues, potentially regulating complex assembly and function
• Ubiquitination: May be targeted for degradation in response to cellular stress
• Acetylation: Lysine acetylation has been detected and may regulate protein-protein interactions

Function

VPS53 functions as a critical component of the HOPS and CORVET tethering complexes, which mediate membrane fusion in the endosomal-lysosomal pathway:

HOPS Complex Function

The HOPS complex (comprising VPS11, VPS16, VPS18, VPS33A/B, VPS39, and VPS53) is the central coordinator of lysosomal fusion events ([Spang, 2016](https://pubmed.ncbi.nlm.nih.gov/27329195/)):

CORVET Complex Function

The CORVET complex (VPS11, VPS16, VPS18, VPS33A/B, VPS39, and VPS53) shares core subunits with HOPS but has distinct functions:

Specific VPS53 Functions

Beyond being a core complex member, VPS53 has specific functions:

• Complex stability: VPS53 is essential for maintaining the structural integrity of the HOPS complex
• SNARE regulation: Works with VPS33 (SM protein) to regulate SNARE complex assembly for membrane fusion
• Cargo recognition: Helps recruit cargo-containing vesicles to the fusion site
• Membrane tethering: Directly participates in tethering vesicles to their target membranes

Synaptic Function

VPS53 is particularly important in neurons ([Harris et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32977321/)):

• Synaptic vesicle recycling: Mediates endosomal trafficking required for synaptic vesicle reformation
• Lysosomal function in synapses: Essential for degradation of synaptic proteins and organelles at synaptic terminals
• Neuronal homeostasis: Maintains endolysosomal system function critical for neuronal health

Expression Pattern

VPS53 exhibits a broad expression pattern with particularly high levels in the nervous system:

High expression in:

• Brain (neurons throughout CNS)
• Spinal cord
• Liver
• Kidney
• All tissues with high endosomal-lysosomal activity

• Cytoplasmic pools associated with endosomes and lysosomes
• Enriched in neuronal soma and synaptic regions
• Co-localizes with late endosomal/lysosomal markers

• Cerebral [cortex](/brain-regions/cortex) (all layers)
• [Hippocampus](/brain-regions/hippocampus) (CA1-CA3, dentate gyrus)
• Cerebellum (Purkinje cells, granule cells)
• Basal ganglia
• Spinal cord motor neurons
• Peripheral neurons

Interaction Network

VPS53 interacts with multiple proteins within the HOPS/CORVET complexes and with regulatory proteins:

| Protein | Interaction Type | Function |
|---------|------------------|----------|
| VPS11 | Direct binding | Core HOPS/CORVET subunit |
| VPS16 | Direct binding | Core complex member |
| VPS18 | Direct binding | Core complex member |
| VPS33A/B | Direct binding | SM protein regulator |
| VPS39 | Direct binding | HOPS-specific subunit |
| VPS52 | Complex formation | CORVET-specific subunit |
| Rab7 | GTPase interaction | Late endosomal regulation |
| SNARE proteins | Regulation | Membrane fusion machinery |
| LAMP1/2 | Co-localization | Lysosomal membrane protein |
| mTOR | Signaling | Nutrient sensing regulation |

Role in Cellular Processes

Autophagy

VPS53 is critical for autophagosome-lysosome fusion ([Zhang et al., 2021](https://pubmed.ncbi.nlm.nih.gov/34254289/)):

• Required for the final step of autophagosome maturation
• Facilitates the recruitment of lysosomes to autophagosomes
• Dysfunction leads to accumulation of undigested autophagic material
• Essential for clearance of protein aggregates in neurons

Endosomal Trafficking

VPS53 mediates multiple endosomal trafficking steps ([Nomura et al., 2016](https://pubmed.ncbi.nlm.nih.gov/27092473/)):

• Early endosome homotypic fusion (via CORVET)
• Late endosome maturation and movement
• Endosome-to-Golgi retrieval
• Endosome-to-lysosome delivery

Lysosomal Function

VPS53 maintains lysosomal homeostasis ([Ballabio & Bonifacino, 2021](https://pubmed.ncbi.nlm.nih.gov/34239133/)):

• Regulates lysosomal fusion events
• Maintains lysosomal pH and enzymatic activity
• Coordinates lysosomal positioning
• Supports lysosome regeneration

Disease Associations

Hereditary Spastic Paraplegia (HSP)

VPS53 mutations cause autosomal recessive hereditary spastic paraplegia with neurodevelopmental regression ([Marti et al., 2021](https://pubmed.ncbi.nlm.nih.gov/34193669/)):

• Clinical features: Progressive lower limb spasticity, developmental regression, ataxia
• Neuropathology: Cerebellar atrophy, cortical thinning, axonal degeneration
• Mechanism: Loss of HOPS function leads to impaired lysosomal trafficking and subsequent neuronal death
• Onset: Childhood to adolescence

Alzheimer's Disease

VPS53 and the HOPS complex contribute to AD pathogenesis ([Nixon et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28853947/)):

• Autophagy impairment: HOPS dysfunction contributes to impaired autophagic-lysosomal clearance of [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau-protein)
• Lysosomal dysfunction: VPS53 deficits exacerbate lysosomal membrane permeabilization in AD
• Protein aggregate accumulation: Impaired autophagosome-lysosome fusion leads to accumulation of autophagic debris
• Neuronal vulnerability: Synaptic VPS53 dysfunction contributes to early synaptic deficits

Parkinson's Disease

VPS53 is implicated in PD through its role in lysosomal trafficking ([Abeliovich & Slack, 2019](https://pubmed.ncbi.nlm.nih.gov/31768059/)):

• Alpha-synuclein clearance: HOPS-mediated lysosomal function is critical for clearing [alpha-synuclein](/proteins/alpha-synuclein) aggregates
• Lysosomal dysfunction: VPS53 deficits contribute to the lysosomal dysfunction seen in PD brain
• Dopaminergic neuron vulnerability: Impaired protein clearance contributes to nigral neuron death
• LRRK2 connection: VPS53 may interact with LRRK2 pathways in PD pathogenesis

Amyotrophic Lateral Sclerosis (ALS)

VPS53 contributes to ALS through lysosomal dysfunction mechanisms ([Chen et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32601840/)):

• Protein aggregate clearance: Impaired autophagy-lysosomal pathway contributes to TDP-43 and SOD1 aggregate accumulation
• Motor neuron vulnerability: VPS53 dysfunction specifically affects motor neuron survival
• Autophagic stress: Defective autophagosome-lysosome fusion leads to cellular stress
• Therapeutic implications: Enhancing VPS53 function may benefit ALS patients

Huntington's Disease

VPS53 may contribute to Huntington's disease pathogenesis:

• Mutant huntingtin clearance: HOPS-mediated lysosomal function is important for clearing mutant [huntingtin](/proteins/huntingtin) protein
• Vesicular trafficking: Impaired endosomal-lysosomal trafficking affects neuronal function
• Autophagy deficits: Similar to other neurodegenerative diseases, HD shows autophagic dysfunction

Progressive Cerebello-Cerebral Atrophy (PCCA)

VPS53 mutations cause this severe neurodevelopmental disorder ([Feinstein et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30609408/)):

• Clinical phenotype: Early-onset neurodegeneration with cerebellar and cerebral atrophy
• Progressive course: Worsening motor and cognitive function
• Neuropathology: Diffuse brain atrophy, particularly affecting cerebellum and cerebral cortex

Therapeutic Implications

Targeting VPS53 pathways represents a potential therapeutic strategy:

Gene Therapy Approaches

• VPS53 replacement: AAV-mediated delivery of functional VPS53 for genetic deficiency
• HOPS complex enhancement: Overexpression of multiple HOPS subunits to boost function
• SM protein targeting: Modulating VPS33 function to enhance SNARE regulation

Small Molecule Modulators

• Autophagy enhancers: Compounds that boost autophagy to compensate for VPS53 deficits
• Lysosomal function promoters: Drugs that enhance lysosomal activity and fusion
• mTOR inhibitors: Rapamycin and analogs to enhance autophagy flux

Protein Replacement Strategies

• Fusion-promoting compounds: Small molecules that enhance membrane fusion events
• Chaperone approaches: Proteins that stabilize VPS53 and HOPS complex function

Research Models

Studying VPS53 in disease:

• Knockout models: VPS53 knockout mice show embryonic lethality
• Conditional knockouts: Neuron-specific deletion reveals synaptic dysfunction
• iPSC models: Patient-derived neurons with VPS53 mutations for drug screening
• Organoid systems: Brain organoids to model VPS53-related neurodegeneration

Biomarker Applications

VPS53 as a biomarker:

• Lysosomal function marker: VPS53 levels reflect lysosomal health
• Disease progression: Changes in VPS53 may correlate with disease stage
• Therapeutic response: Monitoring VPS53 function could indicate treatment efficacy
• Diagnostic utility: Combined with other lysosomal proteins for neurodegeneration diagnostics

Clinical Relevance

Genetic Testing

VPS53 sequencing is available for:

• Suspected hereditary spastic paraplegia
• Unexplained cerebellar ataxia
• Early-onset neurodegenerative disease

Potential Therapeutics

• Gene therapy: AAV-VPS53 for VPS53-related disease
• Autophagy enhancers: Rapamycin, metformin for functional compensation
• Lysosomal modulators: Compounds that enhance lysosomal function

Conclusion

VPS53 represents a critical nexus in the endosomal-lysosomal pathway, serving as an essential component of the HOPS and CORVET tethering complexes that mediate membrane fusion events fundamental to cellular homeostasis. The protein's central role in autophagy, lysosomal trafficking, and synaptic function makes it particularly important for neuronal health, given the unique degradative challenges faced by long-lived neurons. The identification of VPS53 mutations causing hereditary spastic paraplegia has established a direct link between VPS53 dysfunction and human neurological disease, while research into common neurodegenerative diseases has revealed contributions to Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease through impaired autophagic-lysosomal clearance. Understanding VPS53 function and developing therapeutic strategies to enhance its activity represents an important frontier in neurodegenerative disease research.

See Also

• [VPS53 Gene](/genes/vps53)
• [HOPS Complex](/proteins/hops-complex-protein)
• [Lysosomal Trafficking](/mechanisms/lysosomal-trafficking)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosome-neurodegeneration)
• [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Synaptic Vesicle Recycling](/mechanisms/synaptic-vesicle-recycling)

External Links

• [UniProt: Q9H5R0](https://www.uniprot.org/uniprot/Q9H5R0)
• [NCBI Gene: VPS53](https://www.ncbi.nlm.nih.gov/gene/27152)
• [PDB: 6Q19](https://www.rcsb.org/structure/6Q19)
• [HOPS Complex Database](https://www.proteomicsdb.de/)

References